Alterations in Functional Network Reorganization ID'd in Meniere Disease
By Elana Gotkine HealthDay Reporter
FRIDAY, Nov. 3, 2023 -- Alterations in functional network reorganization may serve as potential biomarkers for clinical progression in Meniere disease (MD), according to a study published online Oct. 5 in Scientific Reports.
Jing Li, from Huazhong University of Science and Technology in Wuhan, China, and colleagues examined intranetwork and internetwork connectivity differences between 55 MD patients and 70 healthy controls (HC) in nine well-defined resting-state networks.
The researchers found that in 19 brain areas involved in the somatomotor, auditory, ventral attention, default mode, limbic, and deep gray matter networks, the degree of functional connectivity was lower in MD versus HC. In addition, lower intranetwork connectivity was seen in the auditory, ventral attention, and limbic networks, and internetwork connectivity was lower between the somatomotor and limbic networks, between the auditory and somatomotor, deep gray matter, and ventral attention networks, and between the deep gray matter and default mode network. Eighty-one pairs of brain areas were identified with significant differences in functional connectivity between MD patients and HC at the edge level. There were positive correlations seen between the degree of the left amygdala functional connectivity with MD disease stage and between the ventral attention network intranetwork connectivity with healthy side vestibular ratio.
"These findings expand our understanding of the neural mechanisms underlying the disease and shed light on the functional implications of altered connectivity patterns," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted November 2023
Read this next
AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours
WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
Patient–Primary Care Provider Language Concordance Tied to Better Outcomes
TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.